Management ChangeSep 2, 2026, 06:08 AM
Alterity Therapeutics Files 6-K; Director Interest Notice Filed
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on September 2, 2026. The filing includes Exhibit 99.1, which is a Change of Director's Interest Notice related to Stamler. This report is being incorporated by reference into the company's existing Registration Statements on Form S-8 and Form F-3.
Key Highlights
- Alterity Therapeutics Limited filed a Form 6-K on September 2, 2026.
- Exhibit 99.1 details a Change of Director's Interest Notice concerning Stamler.
- The filing is incorporated by reference into several Registration Statements on Form S-8 and Form F-3.
Price Impact
More from ATHE